Reprint

Obstructive Sleep Apnea

Epidemiology, Pathomechanism and Treatment

Edited by
July 2020
96 pages
  • ISBN978-3-03936-078-9 (Hardback)
  • ISBN978-3-03936-079-6 (PDF)

This book is a reprint of the Special Issue Obstructive Sleep Apnea: Epidemiology, Pathomechanism and Treatment that was published in

Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare
Summary

Obstructive sleep apnea (OSA) is a common disease that may affect up to 50% of the adult population and whose incidence, as well as its health and socio-economic burden, continues to rise. OSA is a well-known risk factor for motor vehicle accidents and decreased work performance, and it is frequently accompanied by cardiovascular diseases. The aim of this Special Issue is to focus on the characteristics of OSA in special populations that are less frequently investigated. For this purpose, seven groups of experts in the field of sleep medicine contributed noteworthy manuscripts on this subject. The content of these articles, which include the latest knowledge about the epidemiology, pathophysiology and comorbidities of OSA in special populations, will support all physicians who endeavor to improve their understanding of this disease and can serve as a basis for future research.

Format
  • Hardback
License
© 2020 by the authors; CC BY-NC-ND license
Keywords
obstructive sleep apnea; non-communicable disease; Modified Berlin Questionnaire; dyslipidemia; body mass index; waist circumference; obstructive apnea; heart failure; risk factors; elderly; comorbidities; Berlin Questionnaire; Epworth Sleepiness Scale; nursing staff; Obstructive Sleep Apnea Syndrome; risk assessment; obstructive sleep apnea; inflammation; FeNO; exhaled breath condensate; volatile organic compounds; polysomnography; heavy equipment operators; STOP BANG Questionnaire; Obstructive Sleep Apnea Syndrome; biomarkers; fibrinolysis; inflammation; OSAHS; sleep disordered breathing; obstructive sleep apnea; continuous positive airway treatment; cardiopulmonary exercise testing; functional capacity; cardiovascular rehabilitation; obstructive sleep apnea; sleep disordered breathing; cardiovascular comorbidities; biomarkers; inflammation; volatile organic compounds; accident risk; non-communicable diseases; risk assessment